RIVASTIGMINA RATIO 13,3 MG/24 H PARCHES TRANSDERMICOS EFG

Ratiopharm Espana S.A.🇪🇸 Spanish Agency of Medicines and Medical Devices

Approval Id: 8b7b9d8255c100c6
Drug Cima Aemps Name: RIVASTIGMINA RATIO 13,3 MG/24 H PARCHES TRANSDERMICOS EFG
Register Number: 86824
Holder Company Name: Ratiopharm Espana S.A.
Marketing Company Name: Ratiopharm Espana S.A.
Authorization Date: 2022-04-12
Dosage Form: PARCHE TRANSDÉRMICO
Dose: 13,3 mg/24 h
Route Of Administration: VÍA TRANSDÉRMICA
Prescription Type: Diagnóstico Hospitalario
Commercialized: No
Company Name: Ratiopharm Espana S.A.

RIVASTIGMINA

19,2 mg

Approved

Agency

CIMA-AEMPS

Country

🇪🇸

Approval Date

Apr 12, 2022

Approval ID

8b7b9d8255c100c6

Type

Standard